Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Novo Nordisk has a GLP-1 pill for diabetes, Rybelsus, but its not as effective for weight loss as injectable versions and was never approved for weight management
By acting as a long-acting amylin analog, it tackles weight control through a unique mechanism: slowing gastric emptying, boosting satiety, and reducing overall caloric intake
Sleep Prioritization: Dr
Ingredients Water(Aqua), Glycerin, 1,2-Hexanediol, Polyglyceryl-10 Laurate, Hydrogenated Lecithin, Glutathione, Butylene Glycol, Chondrus Crispus Powder, Agar, Tromethamine, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Gellan Gum, Glycereth-26, Glyceryl Acrylate/Acrylic Acid Copolymer, Methylpropanediol, Vinyl Dimethicone, Dimethiconol, Niacinamide, Betaine, Sodium Polyacrylate, C18-21 Alkane, Polyglyceryl-10 Oleate, Isononyl Isononanoate, Isohexadecane, Ammonium Acryloyldimethyltaurate/VP Copolymer, Phenyl Trimethicone, Fragrance, Limonene, Citral, Ethylhexylglycerin, Xanthan Gum, Adenosine, Glucose, Caprylic/Capric Triglyceride, Ceramide NP, Palmitoyl Tripeptide-5, Sorbitan Laurate, Hydroxyethylcellulose, Acetyl Dipeptide-1 Cetyl Ester, Acetyl Hexapeptide-1, Thioctic Acid, Soluble Collagen CUSTOMER REVIEWS
This launch significantly improves affordability, bringing effective GLP-1 therapy within reach for nearly 70 percent of Indias diabetes patient population
This gives people an alternative to injectable semaglutide backed by strong clinical evidence
US$ 29.87
US$ 23.74
US$ 20.90
US$ 29.44
